Oct 7, 2026 08:01AM
Oct 7, 2026 08:00AM
Sep 14, 2026 08:00AM
Sep 14, 2026 08:00AM
Sep 10, 2026 08:00AM
Aug 4, 2026 08:00AM
Aug 3, 2026 08:00AM Lipocine names former Johnson & Johnson executive to its board
Aug 3, 2026 08:00AM
Jun 4, 2026 08:00AM
May 19, 2026 08:01AM
May 19, 2026 08:00AM
May 19, 2026 04:00AM
May 18, 2026 08:00AM
May 7, 2026 04:05PM Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026
Apr 2, 2026 08:02AM
Apr 2, 2026 08:00AM
Mar 10, 2026 08:00AM
Feb 18, 2026 08:01AM
Feb 18, 2026 08:00AM
Jan 20, 2026 08:01AM
Jan 20, 2026 08:00AM Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)
Jan 19, 2026 12:20PM
Jan 12, 2026 08:01AM
Jan 12, 2026 08:00AM
Dec 16, 2025 08:00AM
Dec 16, 2025 08:00AM
Nov 18, 2025 08:01AM
Nov 18, 2025 08:00AM Lipocine Highlights Promising Interim Safety Profile in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)
Nov 6, 2025 08:00AM
Nov 4, 2025 08:00AM
Sep 30, 2025 08:01AM
Sep 30, 2025 08:00AM
Sep 5, 2025 04:30PM
Aug 26, 2025 08:00AM
Aug 5, 2025 08:00AM Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2025
Jun 30, 2025 06:53AM
Jun 26, 2025 08:04AM
Jun 26, 2025 08:00AM
Jun 23, 2025 08:00AM
Jun 10, 2025 06:41AM
Jun 9, 2025 08:02AM
Jun 9, 2025 08:00AM Lipocine Announces Filing of New Drug Submission for TLANDO® in Canada
May 22, 2025 08:00AM
May 14, 2025 08:00AM
May 8, 2025 08:00AM
May 6, 2025 08:07AM
May 6, 2025 08:00AM
Mar 26, 2025 08:00AM
Mar 13, 2025 08:00AM Lipocine Announces Financial Results for the Full Year Ended December 31, 2024
Mar 12, 2025 08:00AM

334,880 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All